Post-acute COVID-19 Respiratory Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-06-23
Clinical Trial Results: LYT-100 in Post-acute COVID-19 Respiratory Disease [Phase 2]
Phase 2 trial results for LYT-100 in post-acute COVID-19 respiratory disease have been terminated with results posted.